Flash glucose monitoring: The societal net cost of offering flash glucose monitors to people with type 2 diabetes on insulin treatment in Norway
Original title: Flash glucose-måling: Totalkostnaden ved å tilby flash glukosemåling til personer med insulinkrevende diabetes type 2 i Norge
Flash Glucose Monitors are medical devices that help people with diabetes monitor their blood sugar. The devices offer people with diabetes an alternative to the conventional finger pricking method.
Academic research suggests that using a flash glucose monitor can reduce the risk of harmful and unpleasant complications from diabetes, such as hypoglycaemia and late-stage complications, leading to lower use of healthcare services and improved labour market participation for the users of flash glucose monitors. Due to these positive effects, the societal net costs of offering flash glucose monitors to patients are significantly lower than the purchasing cost of the monitors.
The main conclusions of our study are
- The net cost of offering flash glucose monitors to people with type 2 diabetes on insulin treatment in Norway is lower than the purchasing cost
- If people with type 2 diabetes on basal- and bolus-insulin followed clinical guidelines for how often they should prick their fingers, Flash Glucose Monitors would be cheaper for public budgets than finger pricking – even without accounting for the societal benefits of Flash Glucose Monitors
- Flash Glucose Monitors increase users’ quality of life
- Flash Glucose Monitors are cost-efficient; the cost per QALY is far below the Norwegian threshold value
The study (available below in Norwegian) is commissioned by Abbott Norway.